PME

0.71%

$179.02 pro medicus limited

Thanks, DownanoutRead a little, not exactly light reading.Can...

First 4 Last

Share
Profile

Follow
impressario

408 Posts.

16

28/02/24

12:03

Post #: 72641724
Share

Originally posted by Downanout: ↑

The academic research indicates that, in general, buy-backs are a good sign and a harbinger of above average returns for stock holders.
Management engaging in a buy-back is the opposite of splurging spare cash on some empire building acquisition that doesn’t work out in the end.
It amounts to the company saying that of all the investment opportunities that they can see, buying back their own stock at the prevailing prices is as good as any.
In making that decision, management has the benefit of all the inside information that they know about their own company’s prospects.
It’s trading with inside information that is allowed.
If a company has the necessary cash and sets out to buy back 5 or 10% of its stock that will obviously have some effect on the market for the stock.

However, PME is somewhat of a special case because of their high PE.
They never have enough spare cash to affect the market by force of money.
Rather, for PME a buyback is just a signal..
PME is saying that, knowing what they know about the business, the shares look like value to them.
Given PME’s long term price chart, it’s obvious that any share that they have brought back in the past have been good investments.
However, if you go back and check the detail, they didn’t buy at local peaks, rather they tended to buy at local troughs.
Investors could have done worse than taking their cue from the company’s buyback purchases.
Of course, a decision to buy back stock can be a self-fulfilling to some extent because the fact of buying back shares will affect the market if the market believes the signal that is being sent.
Has PME got it right this time?
You will have to ask that well known Italian gentleman.

Here is some further reading.
“Share Buyback and Equity Issue Anomalies Revisited”
http://www.dimfunds.com/wp-content/uploads/2016/03/Share-Buyback-and-Equity-Anomaly-Revisited-Feb-2016.pdf

Cheers

Expand

Thanks, Downanout

Read a little, not exactly light reading.

Can see somewhat the reasoning behind it. Also, the errors of doing it.
Hope its money well spent.

PME Price at posting: $99.45 Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

There are more pages in this discussion • 57 more messages in this thread...

First 4 Last

Add PME (ASX) to my watchlist

(20min delay)
Last $179.02		Change 1.260(0.71%)		Mkt cap ! $18.70B

Open	High	Low	Value	Volume
$177.38	$181.28	$177.00	$24.00M	133.9K

Buyers (Bids)

No.	Vol.	Price($)
2	121	$179.00

Sellers (Offers)

Price($)	Vol.	No.
$179.25	275	1

View Market Depth

No.	Vol.	Price($)
2	121	179.000
1	80	178.000
1	55	177.760
1	50	177.750
1	82	177.000

Price($)	Vol.	No.
179.250	275	1
180.080	225	1
180.880	1000	1
181.000	700	2
181.300	5	1

Last trade - 16.10pm 04/10/2024 (20 minute delay)

PME (ASX) Chart

Thanks, DownanoutRead a little, not exactly light reading.Can...

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks, DownanoutRead a little, not exactly light reading.Can...

Top Stories

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News